Skip to main content
. 2025 Nov 25;15(12):1805. doi: 10.3390/life15121805
AKI Acute Kidney Injury
BMI Body Mass Index
CAP Controlled Attenuation Parameter
CD36 Cluster of Differentiation 36
CKD Chronic Kidney Disease
CT Computed Tomography
DAG Diacylglycerol
DKD Diabetic Kidney Disease
EASL European Association for the Study of the Liver
ECM Extracellular Matrix
ER Endoplasmic Reticulum
ESKD End-Stage Kidney Disease
eGFR Estimated Glomerular Filtration Rate
FFA Free Fatty Acids
FGF21 Fibroblast Growth Factor 21
GLP-1 RAs Agonists of the glucagon-like peptide-1 receptor
GLUT4 Glucose Transporter Type 4
IDEAL Iterative Decomposition of water and fat with Echo Asymmetry and Least-squares estimation (MRI sequence)
IL-1β Interleukin-1 beta
IL-6 Interleukin-6
IL-18 Interleukin-18
IR Insulin Resistance
KDIGO Kidney Disease: Improving Global Outcomes
KIM-1 Kidney Injury Molecule-1
L-FABP Liver-type Fatty Acid-Binding Protein
LDL Low-Density Lipoprotein
MASLD Metabolic Dysfunction-Associated Steatotic Liver Disease
MASH Metabolic Dysfunction-Associated Steatohepatitis
MRI Magnetic Resonance Imaging
NAFLD Non-Alcoholic Fatty Liver Disease
NGAL Neutrophil Gelatinase-Associated Lipocalin
NLRP3 NOD-Like Receptor Protein 3 (inflammasome)
Ox-LDL Oxidized Low-Density Lipoprotein
PNPLA3 Patatin-Like Phospholipase Domain-Containing 3
ROS Reactive Oxygen Species
RSF Renal Sinus Fat
SGLT2 Sodium-glucose cotransporter-2
T2DM Type 2 Diabetes Mellitus
TAG Triacylglycerol
TLR4 Toll-Like Receptor 4
TNF-α Tumor Necrosis Factor Alpha
UDFF Ultrasound-Derived Fat Fraction
UPR Unfolded Protein Response
uL-FABP Urinary Liver-Type Fatty Acid-Binding Protein
uPTM-FetA Urinary Post-Translationally Modified Fetuin-A
VLDL Very-Low-Density Lipoprotein